Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results

Eurosurveillance

Volumn 20, Issue 5, 2015, Pages 1-7

  Pebody, R G ^a   Warburton, F ^a   Ellis, J ^a   Andrews, N ^a   Thompson, C ^a   Wissmann, B Von ^b   Green, H K ^a   Cottrell, S ^c   Johnston, J ^d   De Lusignan, S ^e   Moore, C ^c   Gunson, R ^f   Robertson, C ^g,h   McMenamin, J ^b   Zambon, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c PUBLIC HEALTH WALES   (United Kingdom)

^d PUBLIC HEALTH AGENCY   (United Kingdom)

^e ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^f West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^g UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^h INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANTIGENICITY; ARTICLE; CONSULTATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PHYLOGENY; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SOUTHERN HEMISPHERE; UNITED KINGDOM; VACCINATION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; AGE; DISEASE ACTIVITY; GENDER; INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; IRELAND; NUCLEOTIDE SEQUENCE; PUBLIC HEALTH SERVICE; SEASONAL VARIATION; VIRUS STRAIN; ADOLESCENT; AGE DISTRIBUTION; CASE CONTROL STUDY; CHILD; CLASSIFICATION; GENETICS; IMMUNOLOGY; INFANT; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; NEWBORN; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SEASON; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUESTIONNAIRES; REAL-TIME POLYMERASE CHAIN REACTION; SEASONS; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84922806328     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.5.21025     Document Type: Article

References (18)

1. Department of Health. Public Health England. The national flu immunisation programme 2014/15. London: Public Health England. 28 Apr 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/316007/FluImmunisationLetter2014_accessible.pdf
2. Public Health England (PHE). PHE Weekly National Influenza Report week 4 report. London: PHE. 22 Jan 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/397454/Weekly_report_ current_week_4x.pdf
3. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062-7. http://dx.doi.org/10.1136/jech.2009.093450 PMID:19910645
4. Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill. 2014;19(27): 20851. http://dx.doi.org/10.2807/1560-7917.ES2014.19.27.20851 PMID:25033051
5. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 2009;14(22):19230. PMID:19497254
6. Gunson R, Maclean A, Davies E, Bennett S, Miller R, Carman WF. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods. 2010;163(2):258-61. http://dx.doi.org/10.1016/j.jviromet.2009.10.006 PMID:19854220
7. Galiano M, Agapow P-M, Thompson C, Platt S, Underwood A, Ellis J, et al. Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS ONE. 2011;6(8):e23779. http://dx.doi.org/10.1371/journal.pone.0023779 PMID:21887318
8. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003;77(15):8418-25. http://dx.doi.org/10.1128/JVI.77.15.8418-8425.2003 PMID:12857911
9. Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313].
10. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725-9. http://dx.doi.org/10.1093/molbev/mst197 PMID:24132122
11. Centers for Disease Prevention and Control (CDC). CDC Health Advisory Regarding the Potential for Circulation of Drifted Influenza A (H3N2) Viruses. Atlanta: CDC. 3 Dec 2014. Available from: http://emergency.cdc.gov/HAN/han00374.asp
12. Broberg E, Snacken R, Adlhoch C, Beauté J, Galinska M, Pereyaslov D, et al. Start of the 2014/15 influenza season in Europe: drifted influenza A (H3N2) viruses circulate as dominant subtype. Euro Surveill. 2015;20(4):p21023. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21023
13. World Health Organization (WHO). Review of the 2014 influenza season in the southern hemisphere. Wkly Epidemiol Rec. 2014;89(48):529-41.
14. ECDC Circulation of drifted influenza A(H3N2) viruses in the EU/ EEA http://ecdc.europa.eu/en/publications/Publications/RRA-InfluenzaA-H3N2-Dec-2014.pdf
15. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. www.eurosurveillance.org 1990;8(1):737-87. http://dx.doi.org/10.1146/annurev. iy.08.040190.003513 PMID:2188678
16. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, january 2015. MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5. PMID:25590680
17. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Dickinson JA, Winter AL, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015. Euro Surveill. 2015;20(4):21022.
18. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. Geneva: WHO; 22-24 Sept 2014. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/consultation201409/en/7